PGR and breast cancer: A recent review highlighted the preclinical and clinical research progress within the last 5 years of ER imaging with 18F-fluoroestradiol (18F-FES) and PR imaging with 18F-fluorofuranyl norprogesterone (18F-FFNP) in breast cancer (Kumar et al., 2020).